LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.26 | 27.76 | 5438 | 6465 | 0.8411 | 0.9565 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.97 | 27.76 | 3992 | 6656 | 0.5997 | 0.8747 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.97 | 27.76 | 4014 | 6656 | 0.6030 | 0.8760 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.97 | 27.76 | 5641 | 6656 | 0.8474 | 0.9586 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.97 | 27.76 | 5671 | 6656 | 0.8519 | 0.9599 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.67 | 27.76 | 4051 | 6695 | 0.6050 | 0.8770 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.67 | 27.76 | 4076 | 6695 | 0.6088 | 0.8784 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.67 | 27.76 | 5827 | 6695 | 0.8703 | 0.9652 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.67 | 27.76 | 5857 | 6695 | 0.8747 | 0.9665 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.37 | 27.76 | 4168 | 6879 | 0.6059 | 0.8779 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.37 | 27.76 | 4189 | 6879 | 0.6089 | 0.8791 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.37 | 27.76 | 5955 | 6879 | 0.8657 | 0.9641 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.37 | 27.76 | 5986 | 6879 | 0.8702 | 0.9653 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.08 | 27.76 | 4258 | 6849 | 0.6216 | 0.8839 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.08 | 27.76 | 4280 | 6849 | 0.6248 | 0.8851 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.08 | 27.76 | 6133 | 6849 | 0.8954 | 0.9724 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.08 | 27.76 | 6158 | 6849 | 0.8990 | 0.9734 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.78 | 27.76 | 4304 | 6893 | 0.6244 | 0.8850 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.78 | 27.76 | 4333 | 6893 | 0.6286 | 0.8866 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.78 | 27.76 | 6285 | 6893 | 0.9118 | 0.9769 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.78 | 27.76 | 6311 | 6893 | 0.9156 | 0.9779 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.48 | 27.76 | 4382 | 6957 | 0.6298 | 0.8873 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.48 | 27.76 | 4415 | 6957 | 0.6345 | 0.8891 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.48 | 27.76 | 6444 | 6957 | 0.9262 | 0.9808 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.48 | 27.76 | 6477 | 6957 | 0.9309 | 0.9821 | MN20160318_Q01 | N08 |